经皮冠状动脉介入治疗患者造影剂肾病的发病率及其相关因素

    Morbidity and related factors of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention

    • 摘要: 目的:调查分析他汀类药物和充分水化治疗后经皮冠状动脉介入(PCI)治疗患者的造影剂肾病(CIN)发病率和可能的危险因素。方法:连续入选PCI治疗的冠心病患者,分析PCI前后肾功能指标的变化,计算CIN的发病率,比较CIN组和非CIN组的相关指标,寻找可能的危险因素。结果:1本组患者CIN发病率为13.8%;2多因素相关性分析发现高龄、内生肌酐清除率、贫血、高血压是CIN的危险因素。结论:PCI患者正规治疗后CIN发病率与文献报道CIN平均发病率相比无明显降低,高龄、内生肌酐清除率、贫血、高血压病是CIN的独立危险因素。

       

      Abstract: AIM: To investigate the morbidity and risk factors of contrast-induced nephropathy( CIN) in patients undergoing percutaneous coronary intervention( PCI) after conventional treatment,including risk assessment before PCI,optimal hydration before and after PCI and statin therapy. METHODS: One hundred and eighty-one consecutive patients who underwent hydration and PCI were enrolled. Serum creatinine was measured before and 72 h after PCI. RESULTS: The morbidity of CIN was 13. 8%. Multiple logistic regression analyses showed that CIN was associated with pre-contrast creatinine clearance,old age,lower hematocrit value and hypertension. CONCLUSION: The morbidity of CIN after conventional treatment is not noticeably lower than the average incidence reported in the literature. Pre-contrast creatinine clearance,old age,anemia and hypertension are independent risk factors for CIN.

       

    /

    返回文章
    返回